Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer

Chinese Academy of Medical Sciences & Peking Union Medical College

Status and phase: Unknown; Phase 2

Conditions: Breast Neoplasms

Treatments: Drug: Exemestane; Drug: aspirin

Study type: Interventional

Funder types: Other

Identifiers

NCT01431053

CH-BC-011

Details and patient eligibility

About

This is a phase II study to assess efficacy/safety of Exemestane with or without Aspirin as the adjuvant treatment in postmenopausal breast cancer patients.

Enrollment: 160 estimated patients

Sex: Female

Ages: 50 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Breast cancer after surgery postmenopausal

Exclusion criteria

• contraindication of aspirin

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

160 participants in 2 patient groups

Exemestane + Aspirin

Experimental group

Treatment:

Drug: aspirin

Drug: Exemestane

Exemestane

Active Comparator group

Treatment:

Drug: Exemestane